|
Q4 2023
|
194 |
303,301 |
AAPL, TPL, IVV, BBIO
|
13F-HR
|
2/5/2024 |
000157029624000002 |
|
Q3 2023
|
190 |
278,212 |
TPL, AAPL, IVV, MDB
|
13F-HR
|
11/8/2023 |
000157029623000008 |
|
Q2 2023
|
191 |
282,023 |
AAPL, TPL, IVV, MDB
|
13F-HR
|
8/9/2023 |
000157029623000006 |
|
Q1 2023
|
184 |
260,523 |
TPL, AAPL, IVV, PLRX
|
13F-HR
|
5/1/2023 |
000157029623000004 |
|
Q4 2022
|
182 |
241,779 |
TPL, IVV, AAPL, PLRX
|
13F-HR
|
2/7/2023 |
000157029623000002 |
|
Q3 2022
|
185 |
237,107 |
TPL, GLOBAL BLOOD THERAPEUTICS INC COM, AAPL, IVV
|
13F-HR
|
11/9/2022 |
000157029622000009 |
|
Q2 2022
|
183 |
232,070 |
TPL, AAPL, IVV, GLOBAL BLOOD THERAPEUTICS INC COM
|
13F-HR
|
8/11/2022 |
000157029622000007 |
|
Q1 2022
|
200 |
284,980 |
AAPL, TPL, MDB, IVV
|
13F-HR
|
5/3/2022 |
000157029622000005 |
|
Q4 2021
|
211 |
305,731 |
MDB, AAPL, IVV, TPL
|
13F-HR
|
2/9/2022 |
000157029622000002 |
|
Q3 2021
|
198 |
291,054 |
MDB, TPL, IVV, AAPL
|
13F-HR
|
10/28/2021 |
000157029621000009 |
|
Q2 2021
|
199 |
302,362 |
TPL, BBIO, IVV, AAPL
|
13F-HR
|
8/5/2021 |
000157029621000007 |
|
Q1 2021
|
190 |
271,928 |
TPL, BBIO, GLOBAL BLOOD THERAPEUTICS INC COM, IVV
|
13F-HR
|
5/6/2021 |
000157029621000005 |
|
Q4 2020
|
183 |
253,683 |
BBIO, GLOBAL BLOOD THERAPEUTICS INC COM, AAPL, MDB
|
13F-HR
|
2/16/2021 |
000157029621000003 |
|
Q3 2020
|
163 |
211,682 |
GLOBAL BLOOD THERAPEUTICS INC COM, AAPL, RLAY, IVV
|
13F-HR
|
11/3/2020 |
000157029620000008 |
|
Q2 2020
|
166 |
202,286 |
GLOBAL BLOOD THERAPEUTICS INC COM, MDB, IVV, AMZN
|
13F-HR
|
8/6/2020 |
000157029620000006 |
|
Q1 2020
|
146 |
156,625 |
GLOBAL BLOOD THERAPEUTICS INC COM, IVV, META, AMZN
|
13F-HR
|
4/30/2020 |
000157029620000004 |
|
Q4 2019
|
159 |
209,094 |
GLOBAL BLOOD THERAPEUTICS INC COM, PTLA, IVV, MYOK
|
13F-HR
|
2/10/2020 |
000157029620000002 |
|
Q3 2019
|
180 |
201,731 |
GLOBAL BLOOD THERAPEUTICS INC COM, PTLA, IVV, MYOK
|
13F-HR
|
11/14/2019 |
000157029619000008 |
|
Q2 2019
|
152 |
182,730 |
GLOBAL BLOOD THERAPEUTICS INC COM, PTLA, MYOK, IVV
|
13F-HR
|
8/1/2019 |
000157029619000006 |
|
Q1 2019
|
155 |
187,425 |
GLOBAL BLOOD THERAPEUTICS INC COM, PTLA, MYOK, IVV
|
13F-HR
|
5/6/2019 |
000157029619000004 |
|
Q4 2018
|
145 |
155,190 |
GLOBAL BLOOD THERAPEUTICS INC COM, MYOK, PTLA, IVV
|
13F-HR
|
2/12/2019 |
000157029619000002 |
|
Q3 2018
|
166 |
189,217 |
GLOBAL BLOOD THERAPEUTICS INC COM, MYOK, PTLA, IVV
|
13F-HR
|
11/13/2018 |
000157029618000009 |
|
Q2 2018
|
157 |
185,278 |
GLOBAL BLOOD THERAPEUTICS INC COM, MYOK, PTLA, IVV
|
13F-HR
|
8/14/2018 |
000157029618000007 |
|
Q1 2018
|
145 |
179,230 |
GLOBAL BLOOD THERAPEUTICS INC COM, MYOK, PTLA, IVV
|
13F-HR
|
5/3/2018 |
000157029618000004 |
|
Q4 2017
|
149 |
186,982 |
GLOBAL BLOOD THERAPEUTICS INC COM, MYOK, PTLA, IVV
|
13F-HR
|
2/5/2018 |
000157029618000002 |
|
Q3 2017
|
138 |
159,730 |
GLOBAL BLOOD THERAPEUTICS INC COM, PTLA, MYOK, MO
|
13F-HR
|
11/9/2017 |
000157029617000009 |
|
Q2 2017
|
138 |
137,849 |
PTLA, GLOBAL BLOOD THERAPEUTICS INC COM, MO, CVS
|
13F-HR
|
8/3/2017 |
000157029617000007 |
|
Q1 2017
|
135 |
125,614 |
GLOBAL BLOOD THERAPEUTICS INC COM, PTLA, MO, CVS
|
13F-HR
|
5/9/2017 |
000157029617000004 |
|
Q4 2016
|
124 |
104,351 |
PTLA, MO, CVS, GILD
|
13F-HR
|
2/14/2017 |
000157029617000002 |
|
Q3 2016
|
124 |
109,165 |
PTLA, CVS, GILD, MO
|
13F-HR
|
11/10/2016 |
000157029616000018 |
|
Q2 2016
|
122 |
102,077 |
PTLA, CVS, MO, GILD
|
13F-HR
|
8/4/2016 |
000157029616000016 |
|
Q1 2016
|
121 |
98,671 |
CVS, GILD, PTLA, MO
|
13F-HR
|
5/10/2016 |
000157029616000014 |
|
Q4 2015
|
126 |
116,990 |
PTLA, GILD, CVS, MO
|
13F-HR
|
2/9/2016 |
000157029616000012 |
|
Q3 2015
|
117 |
114,072 |
PTLA, GILD, CVS, MO
|
13F-HR
|
11/12/2015 |
000157029615000010 |
|
Q2 2015
|
116 |
127,338 |
PTLA, GILD, CVS, BIIB
|
13F-HR
|
8/13/2015 |
000157029615000008 |
|
Q1 2015
|
113 |
121,604 |
PTLA, GILD, CVS, BIIB
|
13F-HR
|
4/30/2015 |
000157029615000006 |
|
Q4 2014
|
109 |
117,554 |
PTLA, GILD, CVS, BIIB
|
RESTATEMENT
|
2/10/2015 |
000157029615000004 |
|
Q3 2014
|
109 |
116,224 |
PTLA, GILD, CVS, IYK
|
13F-HR
|
11/6/2014 |
000157029614000008 |
|
Q2 2014
|
113 |
120,990 |
PTLA, GILD, CVS, GLNG
|
13F-HR
|
7/31/2014 |
000157029614000006 |
|
Q1 2014
|
110 |
107,818 |
CVS, GILD, IYK, BIIB
|
13F-HR
|
4/23/2014 |
000157029614000004 |
|
Q4 2013
|
142 |
150,589 |
PTLA, GILD, SAFT, CVS
|
13F-HR
|
2/6/2014 |
000157029614000002 |